Free Access
Med Sci (Paris)
Volume 31, Number 1, Janvier 2015
Page(s) 31 - 34
Section Nouvelles
Published online 06 February 2015
  1. Fagot-Campagna A, Romon I, Fosse S, Roudier C Prévalence et incidence du diabète, et mortalité liée au diabète en France. Synthèse épidémiologique. Saint-Maurice : InVS, 2010. [Google Scholar]
  2. Grundy SM, Benjamin IJ, Burke GL, et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American heart association. Circulation 1999 ; 100 : 1134–1146. [CrossRef] [PubMed] [Google Scholar]
  3. Bell DS. Diabetic cardiomyopathy. Diabetes Care 2003 ; 26 : 2949–2951. [CrossRef] [PubMed] [Google Scholar]
  4. Miki T, Yuda S, Kouzu H, Miura T. Diabetic cardiomyopathy: pathophysiology and clinical features. Heart Fail Rev 2013 ; 18 : 149–166. [CrossRef] [PubMed] [Google Scholar]
  5. Duncan JG. Mitochondrial dysfunction in diabetic cardiomyopathy. Biochim Biophys Acta 2011 ; 1813 : 1351–1359. [CrossRef] [PubMed] [Google Scholar]
  6. Opie LH. Heart physiology. From cell to circulation. Philadelphia, PA, USA : Lippincott Williams and Wilkins, 2004 : 648 p. [Google Scholar]
  7. Hue L, Taegtmeyer H. The Randle cycle revisited: a new head for an old hat. Am J Physiol Endocrinol Metab 2009 ; 297 : E578–E591. [CrossRef] [PubMed] [Google Scholar]
  8. Lopaschuk GD, Ussher JR, Folmes CD, et al. Myocardial fatty acid metabolism in health and disease. Physiol Rev 2010 ; 90 : 207–258. [CrossRef] [PubMed] [Google Scholar]
  9. Szczepaniak LS, Victor RG, Orci L, Unger RH. Forgotten but not gone: the rediscovery of fatty heart, the most common unrecognized disease in America. Circ Res 2007 ; 101 : 759–767. [CrossRef] [PubMed] [Google Scholar]
  10. Harmancey R, Wilson CR, Taegtmeyer H. Adaptation and maladaptation of the heart in obesity. Hypertension 2008 ; 52 : 181–187. [CrossRef] [PubMed] [Google Scholar]
  11. Fu S, Yang L, Li P, et al. Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity. Nature 2011 ; 473 : 528–531. [CrossRef] [PubMed] [Google Scholar]
  12. Lamant M, Smih F, Harmancey R, et al. ApoO, a novel apolipoprotein, is an original glycoprotein up-regulated by diabetes in human heart. J Biol Chem 2006 ; 281 : 36289–36302. [CrossRef] [PubMed] [Google Scholar]
  13. Turkieh A, Caubere C, Barutaut M, et al. Apolipoprotein O is mitochondrial and promotes lipotoxicity in heart. J Clin Invest 2014 ; 124 : 2277–2286. [CrossRef] [PubMed] [Google Scholar]
  14. Sauvanet C, Arnauné-Pelloquin L, David C, et al. Dynamique et morphologie mitochondriales : acteurs, mécanismes et pertinence fonctionnelle. Med Sci (Paris) 2010 ; 26 : 823–829. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.